TSC22D4 interacts with Akt1 to regulate glucose metabolism

Area of Science:

• Metabolic disorders
• Molecular signaling pathways
• Diabetes research

Background:

• Maladaptive insulin signaling is central to obesity and diabetes pathogenesis.
• Improving insulin sensitivity is a key therapeutic target for diabetes.
• The insulin/phosphatidylinositol 3-kinase (PI3K) pathway is critical for insulin signaling.

Purpose of the Study:

• To identify novel regulators of insulin signaling.
• To investigate the role of transforming growth factor-β1 stimulated clone 22 D4 (TSC22D4) in insulin sensitivity.
• To elucidate the interaction between TSC22D4 and protein kinase B/Akt1.

Main Methods:

• Protein-protein interaction studies identifying TSC22D4 as an Akt1 partner.
• In vitro experiments assessing the impact of environmental cues (energy deprivation, refeeding, glucose, insulin) on TSC22D4-Akt1 interaction.
• In vivo studies using liver-specific genetic reconstitution in mice to evaluate the physiological effects of the TSC22D4-Akt1 interaction.

Main Results:

• TSC22D4 was identified as a novel interaction partner for Akt1.
• The TSC22D4-Akt1 interaction is promoted by energy deprivation and oxidative stress, and impaired by refeeding, glucose, and insulin.
• This interaction, mediated by TSC22D4's D2 domain, reduces Akt phosphorylation during starvation, enhancing insulin sensitivity.
• Liver-specific expression of TSC22D4 and Akt1 interaction improved glucose handling and insulin sensitivity in mice.

Conclusions:

• TSC22D4 functions as an environmental sensor modulating insulin signaling.
• The interaction between TSC22D4 and Akt1 plays a crucial role in regulating insulin sensitivity and glucose metabolism.
• Targeting the TSC22D4-Akt1 interaction may offer a novel therapeutic strategy for metabolic disorders.